• Triple-combination therapy for effective management of Type 2 Diabetes Mellitus.
• Contains Metformin Hydrochloride (Sustained Release), Glimepiride, and Voglibose.
• Helps control fasting, postprandial, and overall blood glucose levels.
• Sustained-release metformin ensures prolonged glycemic control.
• Supports improved insulin secretion and sensitivity.
• Reduces intestinal glucose absorption for better post-meal sugar regulation.
• Ideal for patients requiring combination therapy as prescribed by a doctor.
• Quality-assured formulation meeting pharmaceutical standards.
• Convenient oral dosage form for daily diabetes management.

Glycomet Trio 1 is an advanced triple-combination oral anti-diabetic medication designed to help manage Type 2 Diabetes Mellitus effectively. It contains Metformin Hydrochloride (Sustained Release) 500 mg, Glimepiride 1 mg, and Voglibose 0.2 mg—three well-established agents that work synergistically to provide comprehensive glycemic control. This formulation is prescribed when diet, exercise, and single or dual-drug therapies are insufficient to maintain optimal blood sugar levels.

Metformin Hydrochloride (SR) is a biguanide that reduces hepatic glucose production and enhances insulin sensitivity. Its sustained-release formulation ensures gradual absorption, providing prolonged therapeutic action while minimizing gastrointestinal discomfort. This helps maintain steady blood sugar levels throughout the day.

Glimepiride, a sulfonylurea, stimulates the pancreatic beta cells to release insulin. By increasing insulin secretion, it effectively lowers blood glucose levels, particularly after meals. This action plays a crucial role in achieving overall glycemic stability.

Voglibose, an alpha-glucosidase inhibitor, delays the digestion and absorption of carbohydrates in the intestine. This mechanism helps reduce postprandial blood glucose spikes, which are common in individuals with Type 2 Diabetes. By controlling the rise in sugar levels after meals, voglibose contributes significantly to comprehensive diabetes management.

The combination of these three medications offers a multi-targeted approach to blood sugar control. It addresses insulin resistance, insulin deficiency, and excessive glucose absorption, making it highly effective for patients requiring intensified therapy. Regular use under medical supervision, along with a balanced diet and active lifestyle, can help maintain optimal glycemic levels and reduce the risk of long-term complications such as neuropathy, nephropathy, retinopathy, and cardiovascular disorders.

Manufactured by USV Private Limited, a trusted name in diabetes care, Glycomet Trio 1 adheres to stringent quality standards and ensures safety, efficacy, and reliability. Its convenient oral dosage promotes patient compliance and simplifies complex diabetes treatment regimens.

This medication is intended for adults diagnosed with Type 2 Diabetes Mellitus. It is not suitable for individuals with Type 1 diabetes or diabetic ketoacidosis. As it is a prescription-only medicine, it should be used strictly under the guidance of a qualified healthcare professional.

When taken as prescribed, Glycomet Trio 1 supports effective diabetes management, promotes metabolic balance, and enhances overall quality of life. Regular monitoring and adherence to medical advice are essential for achieving the best therapeutic outcomes.

Active Ingredients:

Each tablet contains:

• Metformin Hydrochloride (Sustained Release) – 500 mg.
• Glimepiride – 1 mg.
• Voglibose – 0.2 mg.

• Take this medicine strictly as prescribed by your doctor.
• Swallow the tablet whole with a glass of water.
• Do not crush, chew, or break the tablet.
• Usually taken before or with meals as directed by a healthcare professional.
• Take it at the same time each day for optimal results.
• Follow recommended dietary and exercise guidelines.
• Do not discontinue use without consulting your doctor.

• Prescription-only medication; use under medical supervision.
• Not intended for Type 1 Diabetes Mellitus or diabetic ketoacidosis.
• Monitor blood sugar levels regularly.
• May cause hypoglycemia; avoid skipping meals.
• Inform your doctor about kidney, liver, or heart conditions.
• Avoid excessive alcohol consumption.
• Consult a doctor before use during pregnancy or breastfeeding.
• Inform your healthcare provider about other medications or supplements.
• Store in a cool, dry place away from direct sunlight.
• Keep out of reach of children.

Generic Name: Metformin HCl (SR), Glimepiride & Voglibose Tablets.

Dosage Form: Oral Tablets.

Therapeutic Class: Anti-diabetic (Oral Hypoglycemic Agent).

Indication: Type 2 Diabetes Mellitus.

Prescription Required: Yes.

Storage: Store below 25°C in a dry place, protected from light and moisture.

Q1. What is Glycomet Trio 1 used for?
It is prescribed for the management of Type 2 Diabetes Mellitus to help control blood sugar levels.

Q2. How does Glycomet Trio 1 work?
It combines metformin, glimepiride, and voglibose to improve insulin action, increase insulin secretion, and reduce carbohydrate absorption.

Q3. Is Glycomet Trio 1 a prescription medicine?
Yes, it should only be taken under medical supervision.

Q4. When should I take Glycomet Trio 1?
It is typically taken before or with meals as directed by your doctor.

Q5. Can it cause low blood sugar?
Yes, hypoglycemia may occur, especially if meals are skipped or taken with other antidiabetic medicines.

Q6. Can I consume alcohol while taking this medicine?
Alcohol should be avoided as it may increase the risk of side effects and hypoglycemia.

Q7. Is this medicine suitable for Type 1 diabetes?
No, it is intended only for Type 2 Diabetes Mellitus.

Q8. What should I do if I miss a dose?
Take it as soon as you remember. Skip it if it is close to the next dose. Do not double the dose.

Q9. Who manufactures Glycomet Trio 1?
It is manufactured by USV Private Limited, a reputed pharmaceutical company in India.

Q10. How should this medicine be stored?
Store in a cool, dry place away from direct sunlight and keep it out of reach of children.

Name: USV Private Limited.

Address: Arvind Vithal Gandhi Chowk, BSD Marg, Station Road, Govandi East, Mumbai - 400088. , India.